News & Events

Title Detail
Successful Completion of Two-Day National Seminar

A Two-day National Seminar on: “Recent Trends in Diabetes Research: Emerging Drug Delivery Technologies and Novel Strategies” organized by Girijananda Chowdhury Institute of Pharmaceutical Science (A Unit of Shrimata Shankar Academy Society) in association with Assam Science and Technology University (ASTU), Jalukbari, Guwahati, Institute of Advanced Study in Science and Technology (IASST), Boragaon, Guwahati and Raghavendra Institute of Pharmaceutical Education and Research (RIPER), Anantapuramu, Andhra Pradesh was held  on 6th and 7th March 2019 at the institute campus. The theme of the seminar was: Recent Advancement in Anti-diabetic Products. On the first day at inaugural session Vice Chancellor of ASTU, Dr. Dhiraj Bora, Director of NIPER-GHY, Prof. USN Murty, Scientist of Defense Research Laboratory (DRL), Sonitpur, Prof. Pronabesh Chattopadhyay and Mr. Ratul Das, President, SSA Guwahati, were present. Prof. Gouranga Das, Principal, GIPS delivered the keynote address about the seminar.

The Keynote speakers at the seminar were Dr. Biswaroop Roy Chowdhury, Internationally acclaimed Medical Nutritionist, Indo-Vietnam Board, New Delhi and Dr. Jagat Chandra Bora, Senior scientist, IASST, Guwahati. The other distinguished speakers were Dr. Santosh S Bhujbals, Professor, Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pune, Dr. Barnali S Thakur, Professor, Dr. Ashok Krishna Bhuyan, Diabetologist, GMCH, Guwahati. The speakers shared their knowledge in diabetic complications and innovative progress in research for future treatment strategy.

Over 250 participants represented different streams of research across the country and presented their work in the field of Diabetes. The aim of the seminar was to bring together researchers, medical professionals, diabetologists, academician, medicine manufacturers, students and leading specialists in a common platform to discuss current developments in diabetes worlds and about future trends in cost-effective anti-diabetic drug products.

View file